FDA NDC Directory · JSON-LD · Markdown
NDC 61958-2505 · HUMAN PRESCRIPTION DRUG · TABLET
| Generic name | bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate |
|---|---|
| Labeler / Manufacturer | Gilead Sciences, Inc. |
| Marketing category | New Drug Application (innovator) · App NDA210251 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | BICTEGRAVIR SODIUM (30 mg/1) EMTRICITABINE (120 mg/1) TENOFOVIR ALAFENAMIDE FUMARATE (15 mg/1) |
| Marketing started | 20211007 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).